Ranked above it

Synergy Rx
Sells no GLP-1 at all — and its own terms contradict its "all 50 states" marketing.
#1 on our PT-141 provider ranking, above MintRx at #9.
Read the Synergy Rx review →
Provider review
Its sermorelin headline understates the real monthly price by 16%.
MintRx's own sermorelin page headlines "From $295," then discloses "Billed and shipped monthly. $343 per month" further down the same page — a real, disclosed $48/mo gap once a reader reads the whole page, not a hidden one.
Reviewed by Marcus Webb
Transparency scorecard
2 of 4 disclosed openly
What MintRx discloses about itself, read from its own pages — not estimated.
Pharmacy named & regulated
Not disclosed
Does not name a pharmacy or state a regulatory category anywhere on its own site.
State coverage published
Disclosed
Publishes which states it actually serves.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
Ranked above it

Synergy Rx
Sells no GLP-1 at all — and its own terms contradict its "all 50 states" marketing.
#1 on our PT-141 provider ranking, above MintRx at #9.
Read the Synergy Rx review →What this price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
The catch — Sermorelin's "From $295" headline sits $48/month (16%) below the "$343 per month" figure the same page discloses as the real, billed-and-shipped-monthly rate.
See plans at MintRxPrices read from MintRx's own site · August 2026
What they advertise
Sermorelin "From $295"; PT-141 "$160 first month, then $180/mo"; NAD+ "$195 first month, $225/mo after" (or $585 billed quarterly for a 3-month plan).
What you actually pay
Sermorelin's real, billed-and-shipped-monthly rate is $343/mo, disclosed on the same page as the "From $295" headline. PT-141's real standing rate is $180/mo. NAD+'s real standing rate is $225/mo, both disclosed transparently beside their first-month figures.
MintRx (mintrx.com) is a real, high-volume telehealth pharmacy storefront (2,000+ Trustpilot reviews) selling compounded PT-141, sermorelin and NAD+. It publishes no price for compounded tirzepatide or compounded semaglutide.
MintRx appears on our sermorelin provider ranking, our NAD+ provider ranking and our PT-141 provider ranking. Nothing on this page is a performance claim.
Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.
MintRx does not name the pharmacy that fills your prescription.
Unknown regulatory category. MintRx's own footer names a specific dispensing pharmacy via a BBB Business Review seal — "Medmetrics Compounding Pharmacy" (Chandler, AZ) — plus a LegitScript seal (ID 1056826, confirmed against LegitScript's own registry) — but neither "503A" nor "503B" is stated anywhere on the site checked.
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
List published. The state dropdown on MintRx's own PT-141 intake form lists 34 states plus DC — a real, specific, positive list, not an "all 50" claim.
The part they would rather you skipped
MintRx's own sermorelin page headlines "From $295," undermining the real "$343 per month" standing rate the same page discloses further down — a $48/mo, 16% gap. Its own live Contact page also names a UK office address ("2281 New Way Street, London, United Kingdom") on an otherwise entirely US-facing site (US state dropdown, US phone numbers, US pharmacy) — a discrepancy the site never explains. FDA has issued no warning letter to MintRx.
None of this is unique to MintRx — the whole category shares it.
The providers we rank on our PT-141 provider ranking — the most specific board MintRx sits on — in the order that board ranks them. It sells into other categories too; see the boards listed above under the bottom line.






3 more providers rank on our PT-141 provider ranking — see the full ranking. Every provider we review →
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Ready to get started?
Prices and plans in this category change often — check MintRx's current pricing before you decide. Ours was read from their own site in August 2026.
Facts on this page reflect MintRx's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on MintRx's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.
MintRx
3 compounds from $180/mo